JAMA Oncology Exercise reduces risk of death among select cancer survivors The study appears in the journal JAMA Oncology. This drug ups risk of heart failure in cancer patients The proteasome inhibitor carfilzomib has taken on an increasing role in the treatment of multiple myeloma. « Previous1Next » 1 of 1